{"name":"Vincerx Pharma","slug":"vincerx","ticker":"VINC","exchange":"NASDAQ","domain":"vincerx.com","description":"Vincerx Pharma is a clinical-stage biopharmaceutical company focused on developing innovative oncology therapies, including antibody-drug conjugates (ADCs). The company's pipeline includes several promising candidates, including VX-9970 and VX-387. Vincerx Pharma is positioning itself as a leader in the ADC space, with a strong focus on delivering life-changing treatments to patients with cancer.","hq":"Palo Alto, CA","founded":0,"employees":"","ceo":"Ahmed Hamdy","sector":"Oncology / ADCs","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$180M","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":-30074000,"cash":8005000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2034-06-01","label":"VX-9970 patent cliff ($0.00 at risk)","drug":"VX-9970","type":"patent_expiry","sentiment":"negative"},{"date":"2035-06-01","label":"VX-387 patent cliff ($0.00 at risk)","drug":"VX-387","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-27","type":"regulatory","headline":"Vincerx Pharma Announces FDA Clearance of IND for VX-9970","summary":"Vincerx Pharma announced that the FDA has cleared the Investigational New Drug (IND) application for VX-9970, a novel ADC targeting CDK12.","drugName":"VX-9970","sentiment":"positive"},{"date":"2023-11-14","type":"deal","headline":"Vincerx Pharma Enters into Strategic Collaboration with Merck KGaA","summary":"Vincerx Pharma announced a strategic collaboration with Merck KGaA to develop and commercialize its ADC pipeline, including VX-9970 and VX-387.","drugName":"VX-9970, VX-387","sentiment":"positive"}],"realNews":[{"date":"2025-07-07","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-05-15","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5YQ3pYeTV2cFJhQzlIbW16Yzl5Ujd5MWNmMS1ldHUzXzZsOXoxbGJNYUkzVmczdEttcXBUNmkyaGhCbE90TXpONXJtdzM3bDE0ZDZB?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"VINC Stock Price, News & Analysis | Vincerx Pharma - Stock Titan","headline":"VINC Stock Price, News & Analysis | Vincerx Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTFBKZkdlOGxDUktCYldYd0xvNWVxRm9tbmhEX0xuSEE4UDJtbFFVUnJTUXBpa3d0azFiTE9FOElXdkloS3A5ckNxcE1lX1oxUTFVU1lhSUNoZnU?oc=5","date":"2025-04-24","type":"pipeline","source":"TradingView","summary":"VINC Stock Price and Chart — OTC:VINC - TradingView","headline":"VINC Stock Price and Chart — OTC:VINC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQb2ppR3V5bmwwaEp6NC1QRXRMQ1dWV3dOekFlY0kxZl9Mc2xPN2ZNaTNzVkNrblVyNkpEajlORk9GYjF3OTVLQ29MUGgtdmxpcjFLU3FiM1k3RDhNbmxwRzdEZUMtdVdaR1JSaDZJejNuUTZEUi1oa1d4YXZRUXBIa1F1UU9PeFlGMTEtOUFyT3RzeEVna2dxSjdrZUN0ZmVuaEJzRXdCcV85OVNiOHhwR0wwZHl2eGs?oc=5","date":"2025-04-17","type":"pipeline","source":"Stock Titan","summary":"Vincerx Pharma Announces Complete Liquidation and Nasdaq Exit: What Happens to Your Shares? - Stock Titan","headline":"Vincerx Pharma Announces Complete Liquidation and Nasdaq Exit: What Happens to Your Shares?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxOX2hNUlliQll2NzVmdFVMUGJ1MXRZT1BtdDRfZzREbERBelFHZndxRU5SNGpKZ3A5MzNrbkZ6SmRfVElieE9KX0NaVmZjRGthMmJMOFVyNDFOSU5GRElsX3RDakZkZjRfQ01oX0lmUTZNdm5iV04zdmxfUkcxb1MySjZ3ZVZoRUxLLTNON0FkeGVNMmd6UGRkZFpYRngyODB0bUVNZFNxT2pYczBNSFpJQVhkTkFzWFNaUWdjMlJzNk44U2Q1YnlwTXhuLUhVajFOMlZwQnNJNlE0LTEzZWN0WHNKbFNRN1cxdUVCeUhR?oc=5","date":"2025-04-17","type":"pipeline","source":"globenewswire.com","summary":"Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC - globenewswire.com","headline":"Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNanV6dnl1SGtsUUlBakI3NGZ0NExmOURuanJMeFpRUlByQUxjQlI3MlVKZmc3QVY2NFZKNjlfNTlCeW9qYWlCb1hWRlg5RUVvWTN2N3Bkekxma1FLaVBFVy1WUEFXWXJUdy1MMllkUlJKdnFIb3hjVVdzT1dNcGtGUWZyb2Q3eklZUXNhbzI5NE8zZHNnS0JJNVZ1dW1fUDdXQTdMM0t5a3h4WU0?oc=5","date":"2025-04-09","type":"deal","source":"Fierce Biotech","summary":"Vincerx's final merger attempt collapses, leaving ADC biotech to wind down - Fierce Biotech","headline":"Vincerx's final merger attempt collapses, leaving ADC biotech to wind down","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPdF9qYXlzVXBaNXZlSkRranJ3ZlVDcDlTWHBIMXNZTnpld2k1Q0w5X2FkeFBnaEZKYWNjRzlWV0xaNmRVN25RZ2JlVm5YdjZXTkVKbmpvRFpFaEVSX0trMG01QWhzb2liWmRtVV8tQXpSc1RvWkpjSDNsYWY2LVRqRWdCZGsxT1dXZjRaS1JSSHY0S2pWUjA2QjRVemloeUZMVmhqOFJzUnFLQQ?oc=5","date":"2025-04-08","type":"pipeline","source":"The Business Journals","summary":"Financially struggling drugmaker's potential rescue falls apart. It now will wind down - San Francisco Business Times - The Business Journals","headline":"Financially struggling drugmaker's potential rescue falls apart. It now will wind down - San Francisco Business Times","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAJBVV95cUxQSjhfN1R5T01XT2l5UUN2R09adWduYThldXNkMUpJX1lmUEFJR0FMOU5KOWVuTVh3dHZGZ1BzMjhlWU83dlRCb0w0VjRBdmJ4Nkh1Z1hVaFR3a1R0NjA4dlc2MVpqeVh5RWFBaXFrbFZTQTFCOVBfUGYzYkVoUXJwS3pyems3anVzdndsVlV3UXNVNFQxS0pKVTZnM2F4eHhFLWFwbjFGNzBhVlFUVUtqTmhZMm5kN24xMS1xV0xnR0JubmdfRm5yX3dEMmhnNGozWklnMC1BYS1SeDl0X0ZtbVc0QldfS3diTzl3Zno0aVhpTzRpVzBfemw4eC1UZEUtdGFwNEdRbEVqVEpGQmFiZw?oc=5","date":"2025-04-08","type":"pipeline","source":"globenewswire.com","summary":"Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities - globenewswire.com","headline":"Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNbzBqbkd2Ym1LVGFsQ2VpTkcycDNGRkRySU9UelRONjdHR0dMcW9NdElpSHNRWTE0X0ZfSlNlZzRvQk5fM2NSYktfbXlTQjkzSWZUbjRWQTJDVG9PeTVlSml5bjhsWWN5T2dfd2pzM0REdDU1Sy1HRGM1YVRrRHFNc3ZOa2dWM1dmYkE?oc=5","date":"2025-03-18","type":"pipeline","source":"Yahoo Finance","summary":"Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI - Yahoo Finance","headline":"Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNUnBoeEJDMkg3c0dhOEtyX0o3c2tSTXpJVnZoLWVPWTkxdFhkR19faUpPaHZxWm9sV2M1U1hzd01RaFZVZUJWTG10aldDZkp5Mmw3M1FkelliV1poazdYcUpYemtrSTA1UTExVXpMUjRPT0pYNVEtSnJFVzc3M0o1cHV5aXdTRWVsQWdiSENkTlZHTmIxZEpPUXYxU05ibUt5VmxmUFFUanplQXM?oc=5","date":"2025-03-18","type":"deal","source":"Investing.com","summary":"Vincerx Pharma plans reverse merger with QumulusAI - Investing.com","headline":"Vincerx Pharma plans reverse merger with QumulusAI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxNZlVlc2xoMlhrUHJoZDhIRHFuVHBIYUh2LUowRXFoM3FZdGY4X3ZlTHFFanRPZEpGVFFjOXU0NWtWRkUteE9zYy1yT3kzal9ZaW9KUkw4Y1dsRWtrbmZNRU8wOU5GZy1FMFJpbDRib0hwemMxVGJsYlZZUHdlckZ5WG12bURBNm8?oc=5","date":"2024-12-27","type":"deal","source":"Yahoo Finance","summary":"Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc. - Yahoo Finance","headline":"Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPeVNYaWFCQkdsdnZNSFpSeTBDY2NQTmk5bDQ3U3puZmYxZUdVYV83OFJxTTB2dFlybVR4NDNRWjNqVnJJQ3loaWFMWnBodW0za2dnVTFqV2Mtal9OYUFvN0pzVkRXdUpSSWNod1NVWUU4VzlWdEhaV2dOWUFaNFJoZUhfQUQ1Q25i?oc=5","date":"2024-04-09","type":"pipeline","source":"InvestorPlace","summary":"Why Is Vincerx Pharma (VINC) Stock Down 64% Today? - InvestorPlace","headline":"Why Is Vincerx Pharma (VINC) Stock Down 64% Today?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE9vM0JaTDRQWUp1SlVIRjNDc1dpbUotVS1JakptemhSYl9KMUlydHpTX0xVQVJNTUVrSGFzMVRTTmpGTEp1WjQ0RkdJcGcwblBKWkoyZEhzTnFlQQ?oc=5","date":"2021-01-06","type":"pipeline","source":"MarketBeat","summary":"Vincerx Pharma (VINC) Stock Price, News & Analysis $VINC - MarketBeat","headline":"Vincerx Pharma (VINC) Stock Price, News & Analysis $VINC","sentiment":"neutral"}],"patents":[{"drugName":"VX-9970","drugSlug":"cdk12-adc","patentNumber":"","type":"Patent Cliff","expiryDate":"2034-06-01","territory":"US","annualRevenue":0},{"drugName":"VX-387","drugSlug":"cdk4/6-adc","patentNumber":"","type":"Patent Cliff","expiryDate":"2035-06-01","territory":"US","annualRevenue":0}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":3,"keyCompetitors":["Bristol Myers Squibb","Merck & Co.","AstraZeneca"],"therapeuticFocus":["Oncology","ADCs"],"financials":{"source":"sec_edgar","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":null,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-30074000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":8005000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}